<?xml version="1.0" encoding="UTF-8"?>
<p>Results of percent AChE and BChE activity in frontal cortex and hippocampus of different animal groups in NORT are given in 
 <xref ref-type="fig" rid="brainsci-11-00259-f006">Figure 6</xref>C,D and 
 <xref ref-type="fig" rid="brainsci-11-00259-f007">Figure 7</xref>C,D. Percent AChE and BChE activities in the cortex and hippocampus of scopolamine-treated groups were significantly (
 <italic>p</italic> &lt; 0.001 ***) higher than that of the normal saline group. %AChE and BChE activities in the cortex and hippocampus of Fa.EtAc + Scop (100 mg/kg, p.o.) and Fa.EtAc + Scop (200 mg/kg, p.o.)-treated groups, and standard DZP + Scop (20 mg/kg; (i.p.)-treated groups were significantly (
 <italic>p</italic> &lt; 0.01) 
 <sup>##</sup>; lower as compared to scopolamine-treated group. 
</p>
